Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.uk
Google Alert - "golimumab biosimilar"
Get the latest updates from Google Alert - "golimumab biosimilar" directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 4 days ago
FDA approves denosumab biosimilar Ponlimsi
4 days ago
EC approves golimumab biosimilar Gotenfia and ranibizumab biosimilar Ranluspec. X-ray2 MD001884. Biosimilars/News...
Canada's Jamp Deepens Immunology Biosimilars Push - Citeline News & Insights
7 days ago
Jamp Pharma has secured Health Canada approval for Upgolyv, a golimumab biosimilar...
JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a ...
8 days ago
As a Canadian-owned company, we are proud to offer this authorized golimumab...
JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a ...
8 days ago
JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a Golimumab...
EMA recommends approval of three new biosimilars for diabetes and autoimmune conditions
12 days ago
EC approves golimumab biosimilar Gotenfia and ranibizumab biosimilar Ranluspec · EMA recommends...
Goodwin Advises Tubulis on Acquisition by Gilead for $3.15 Billion Upfront and Up to $1.85 ...
20 days ago
March 26, 2026. Bio-Thera and Intas Expand Golimumab Biosimilar Partnership to India...
FDA Approves Teva Biosimilar for Denosumab in Osteoporosis
28 days ago
Golimumab Biosimilar Matches Reference Drug in Year-Long RA Trial. March 19th 2026...
Bio-Thera And Intas Expand Golimumab Biosimilar Partnership To India - Mondaq
28 days ago
... 2026, Bio-Thera Solutions announced an expansion of its existing partnership with...
Accord and Bio-Thera File Four IPRs Challenging Janssen Simponi® Patents - JD Supra
29 days ago
... (golimumab) Biosimilar). Each petition targets method-of-treatment claims directed to intravenous administration...
Accord, Intas, and Bio-Thera File Four IPRs Against Janssen Golimumab Patents | JD Supra
29 days ago
... Golimumab Biosimilar · Janssen Files BPCIA Complaint Against Bio-Thera and Accord...
Goodwin Advises Quotient Therapeutics on Collaboration With Merck for Up to $2.2 Billion in Total
about 1 month ago
Related Content · Bio-Thera and Intas Expand Golimumab Biosimilar Partnership to India...
Bio-Thera and Intas Expand Golimumab Biosimilar Partnership to India | Goodwin - JDSupra
about 1 month ago
... golimumab biosimilar referencing Janssen's SIMPONI®. The updated agreement grants Intas exclusive...